ReWalk Robotics (NASDAQ:LFWD) Receives “Buy” Rating from HC Wainwright

ReWalk Robotics (NASDAQ:LFWD)‘s stock had its “buy” rating restated by analysts at HC Wainwright in a report issued on Thursday,Benzinga reports. They presently have a $13.00 price target on the stock.

Separately, Laidlaw initiated coverage on ReWalk Robotics in a report on Monday, February 10th. They set a “buy” rating and a $10.00 price objective on the stock.

ReWalk Robotics Stock Down 4.1 %

LFWD stock opened at $1.77 on Thursday. ReWalk Robotics has a 52-week low of $1.25 and a 52-week high of $7.70. The stock’s fifty day simple moving average is $1.74 and its 200-day simple moving average is $2.41. The stock has a market capitalization of $18.76 million, a price-to-earnings ratio of -0.71 and a beta of 2.05.

Insider Activity at ReWalk Robotics

In other news, Director Michael Swinford bought 21,622 shares of ReWalk Robotics stock in a transaction that occurred on Monday, November 25th. The shares were purchased at an average price of $2.03 per share, for a total transaction of $43,892.66. Following the completion of the acquisition, the director now owns 65,040 shares of the company’s stock, valued at $132,031.20. The trade was a 49.80 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, major shareholder Global Fund Lp Lind II sold 381,676 shares of ReWalk Robotics stock in a transaction on Monday, January 6th. The shares were sold at an average price of $3.36, for a total value of $1,282,431.36. Following the completion of the transaction, the insider now owns 1,049,430 shares in the company, valued at $3,526,084.80. The trade was a 26.67 % decrease in their position. The disclosure for this sale can be found here. 2.50% of the stock is owned by insiders.

About ReWalk Robotics

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke.